Eva W. Iepsen
Copenhagen, 2200, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Neprilysin activity is increased in metabolic dysfunction-associated steatotic liver disease and normalizes after bariatric surgery or GLP-1 therapy.
Journal: iScience
Published: May 09, 2023
A Gut-Intrinsic Melanocortin Signaling Complex Augments L-Cell Secretion in Humans.
Journal: Gastroenterology
Published: March 29, 2020
GLP-1 Receptor Agonist Treatment in Morbid Obesity and Type 2 Diabetes Due to Pathogenic Homozygous Melanocortin-4 Receptor Mutation: A Case Report.
Journal: Cell reports. Medicine
Published: September 17, 2019
Adults with pathogenic MC4R mutations have increased final height and thereby increased bone mass.
Journal: Journal of bone and mineral metabolism
Published: June 06, 2019
Patients with Obesity Caused by Melanocortin-4 Receptor Mutations Can Be Treated with a Glucagon-like Peptide-1 Receptor Agonist.
Journal: Cell metabolism
Published: December 19, 2017
Treatment with liraglutide may improve markers of CVD reflected by reduced levels of apoB.
Journal: Obesity science & practice
Published: May 15, 2017
Proteomics reveals the effects of sustained weight loss on the human plasma proteome.
Journal: Molecular systems biology
Published: December 23, 2016
Instrumentalization of Eating Improves Weight Loss Maintenance in Obesity.
Journal: Obesity facts
Published: December 15, 2016
Successful weight loss maintenance includes long-term increased meal responses of GLP-1 and PYY3-36.
Successful weight loss maintenance includes long-term increased meal responses of GLP-1 and PYY3-36.
Journal: European journal of endocrinology
Published: November 13, 2015
Response to the Letter by Napoli N., et al.
Journal: The Journal of clinical endocrinology and metabolism
Published: October 07, 2015
Last Updated: 09/26/2026